C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2001
12/13/2001	WO2001094391A2 Intracellular signaling proteins
12/13/2001	WO2001094383A2 Mutated furin polypeptides having improved characteristics
12/13/2001	WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/13/2001	WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	WO2001093901A1 Combined preparation for the treatment of neoplasic diseases
12/13/2001	WO2001093900A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
12/13/2001	WO2001093898A1 Methods of treating viral diseases with il-18 and il-18 combinations
12/13/2001	WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury
12/13/2001	WO2001093880A1 Production and use of microvessels in a fibronectin-containing gel
12/13/2001	WO2001072772A3 Calcium binding regulatory subunit
12/13/2001	WO2001070968A3 Production of recombinant blood clotting factors in human cell lines
12/13/2001	WO2001059086A3 Methods and constructs for agrobacterium-mediated plant transformation
12/13/2001	WO2001055103A3 Chimeric neuropeptide y receptors
12/13/2001	WO2001046408A3 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/13/2001	WO2001044445A3 Human lyases and associated proteins
12/13/2001	WO2001043694A3 Compositions and methods for caspase-induced apoptosis
12/13/2001	WO2001042784A3 Methods for screening compounds active on neurons
12/13/2001	WO2001038502A3 Oleoyl-acyl-carrier-protein thioesterases in plants
12/13/2001	WO2001030987A3 Tankyrase h, compositions involved in the cell cycle and methods of use
12/13/2001	WO2001027245A3 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells
12/13/2001	WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/13/2001	WO2001015722A3 Methods useful in affecting apoptosis
12/13/2001	WO2000065076A3 Synthetic gene for expressing active retroviral protein in eukaryotes
12/13/2001	WO2000044888A3 Dimethylarginine dimethylaminohydrolases
12/13/2001	WO2000032773A9 Compositions and methods for increasing bone mineralization
12/13/2001	WO2000015845A9 T-type calcium channel
12/13/2001	WO2000008043A9 Prevention and treatment of viral disease
12/13/2001	US20010052136 Compositions and methods for producing and using homogenous neuronal cell transplants
12/13/2001	US20010051834 Method for composite cell-based implants
12/13/2001	US20010051374 High efficiency genetic modification methods
12/13/2001	US20010051373 T-cell clones expressing anti-hiv-1 factors
12/13/2001	US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation
12/13/2001	US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/13/2001	US20010051359 Genetic engineered protein
12/13/2001	US20010051151 In vitro activated gamma delta lymphocytes
12/13/2001	US20010051148 Pretreatment transplantation of organs; genetic engineered culture product
12/13/2001	DE10062626A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix
12/13/2001	DE10062623A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix
12/13/2001	DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control
12/13/2001	DE10026789A1 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation
12/13/2001	DE10026482A1 Verfahren zur Herstellung eines bioartifiziellen Transplantats A process for the preparation of a bioartificial transplant
12/13/2001	DE10026480A1 Verfahren zur Herstellung eines empfängerspezifischen Gewebe-Transplantats oder -Implantats A method for producing a recipient-specific tissue graft or -Implantats
12/13/2001	DE10026442A1 Verfahren zur Herstellung eines empfängerspezifischen Gewebe-Transplantats A method for producing a recipient-specific tissue graft
12/13/2001	CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury
12/13/2001	CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	CA2585822A1 Breast, rectal, colon and lung tumour marker pro19628 polypeptide and encoding nucleic acid
12/13/2001	CA2412436A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
12/13/2001	CA2412382A1 Hy2 family of bilin reductases
12/13/2001	CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	CA2411849A1 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
12/13/2001	CA2411762A1 Method for obtaining characterised muscle-derived cell populations and uses
12/13/2001	CA2411730A1 Tumour suppressor and uses thereof
12/13/2001	CA2411719A1 Novel g-protein coupled receptor
12/13/2001	CA2411609A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/13/2001	CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations
12/13/2001	CA2411285A1 Combined preparation for the treatment of neoplasic diseases
12/13/2001	CA2411069A1 The human voltage gated sodium channel .beta.-1a subunit and methods of use
12/13/2001	CA2410510A1 Artificial antigen presenting cells and methods of use thereof
12/13/2001	CA2410458A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury
12/13/2001	CA2410162A1 Breast, rectal, colon and lung tumor marker pro 4332 polypeptide and encoding nucleic acid
12/13/2001	CA2409392A1 Intracellular signaling proteins
12/13/2001	CA2409342A1 Extracellular messengers
12/13/2001	CA2409197A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
12/13/2001	CA2408748A1 Nuclear hormone receptor
12/13/2001	CA2381249A1 Methods and compositions for modulating oxidized ldl transport
12/12/2001	EP1162458A1 Methods and compositions for modulating oxidized LDL transport
12/12/2001	EP1162273A1 Recombinant DNA vectors for gene therapy
12/12/2001	EP1162269A1 Novel polypeptide
12/12/2001	EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy
12/12/2001	EP1162264A2 Chimeric hormone receptor
12/12/2001	EP1162261A1 Continuous monolayer of primary hepatocytes
12/12/2001	EP1161862A2 See-through medaka
12/12/2001	EP1161558A1 Intact cell assay for protein tyrosine phosphatases
12/12/2001	EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction
12/12/2001	EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
12/12/2001	EP1161546A2 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
12/12/2001	EP1161537A1 Non-spreading pestivirus
12/12/2001	EP1161530A1 Protein for blocking platelet adhesion
12/12/2001	EP1161527A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types
12/12/2001	EP1161523A1 Cells, cell populations, and methods of making and using same
12/12/2001	EP1161522A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides
12/12/2001	EP1161521A2 Transplantation of haematopoietic cells
12/12/2001	EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases
12/12/2001	EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection
12/12/2001	EP1161454A2 Peptides with anti-angiogenic activity
12/12/2001	EP1161450A1 Bone stimulating factor
12/12/2001	EP1161448A1 49 human secreted proteins
12/12/2001	EP1161447A1 50 human secreted proteins
12/12/2001	EP1161446A1 50 human secreted proteins
12/12/2001	EP1161444A1 A novel inhibitor of programmed cell death
12/12/2001	EP1161442A2 Exocytosis pathway proteins and methods of use
12/12/2001	EP1161266A1 Matriptase, a serine protease and its applications
12/12/2001	EP1161142A1 Methods for culturing fluid-filled sensory organs
12/12/2001	EP1151156A4 Luciferase reporter bioassay of parathyroid hormone compounds

1 ... 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 ... 1827